Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital

Anemia is a common pregnancy condition that has multiple origins. Its frequency and severity seem to be increasing, despite the existing management recommendations and the awareness of health professionals. The objective of this study is to make a statement of this pathology within our establishment, to evaluate the proportion of patients presenting this pathology and to highlight possible risk factors.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pregnancy Anemia

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Hôpital Nord Franche-Comté

Trévenans, 90400, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

> 18 years
Delivery at Nord Franche-Comte Hospital
Delivery ≥ 32 weeks of amenorrhea
Informed patient and non-opposition of participation

Exclusion criteria

Protected adults (Patients under guardianship, curatorship, safeguard of justice or under family authorization)
Medical interruption of pregnancy
Patients with fetal death in utero or neonatal death
Minor patients
Premature delivery before 32 weeks

Treatment and study plan

Questionnaire

Other

questionnaire post delivery

Primary outcomes

Estimation of the proportion of patients presenting anemia during delivery

Time frame: 6 month

Percentage of patients with hemoglobin less than 10.5 g/dl at entry into the delivery room

Secondary outcomes

Risk factors underlying anemia during delivery with a large questionnaire

Time frame: 6 month

Link between presence or absence of anemia and type of follow-up (gynecological or midwife, anemia during pregnancy and iron supplementation strategy and compliance), living conditions (geographical origin, socioeconomic situation, diet) and comorbidities

Sponsors and collaborators

Lead sponsor

Hopital Nord Franche-Comte

Other

Registry information

Acronym: ANEMIA

Important dates

Study start: 2021
Primary completion: 2021
Study completion: 2022
First posted: Mar 24, 2021
Registry last updated: Mar 16, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed